FMP

FMP

Enter

PTCT - PTC Therapeutics, In...

photo-url-https://images.financialmodelingprep.com/symbol/PTCT.png

PTC Therapeutics, Inc.

PTCT

NASDAQ

PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on the development of treatments for multiple therapeutic areas, such as rare diseases. The company offers Translarna and Emflaza for the treatment of Duchenne muscular dystrophy in the European Economic Area and the United States, as well as to treat nonsense mutation Duchenne muscular dystrophy in Brazil and Russia; commercializes Tegsedi and Waylivra for the treatment of rare diseases in Latin America and the Caribbean; and markets Evrysdi for the treatment of spinal muscular atrophy in adults and children two months and older in Brazil. The company's splicing platform includes PTC518, which is being developed for the treatment of Huntington's disease. PTC Therapeutics, Inc. has collaborations with F. Hoffman-La Roche Ltd and Hoffman-La Roche Inc., as well as the Spinal Muscular Atrophy Foundation to advance drug discovery and development research in regenerative medicine; and Akcea Therapeutics, Inc. to commercialize Tegsedi and Waylivra for the treatment of rare diseases in Latin America and the Caribbean. PTC Therapeutics, Inc. was incorporated in 1998 and is headquartered in South Plainfield, New Jersey.

54.5 USD

1.74 (3.19%)

Balance Sheet

Year

2020

2021

2022

2023

2024

2025

2026

2027

2028

2029

Total Cash

38.23M

52.17M

32.41M

24.09M

41.27M

26.2M

22.32M

19.01M

16.2M

13.8M

Total Cash %

1.38

2.97

2.06

1.73

2.99

2.23

2.23

2.23

2.23

Receivables

445.9M

258.5M

193.03M

199.72M

147.77M

160.43M

136.68M

116.44M

99.2M

84.51M

Receivables %

16.14

14.7

12.29

14.38

10.71

13.64

13.64

13.64

13.64

Inventories

534.51M

364.68M

421.48M

363.15M

276.42M

265.98M

226.6M

193.05M

164.47M

140.12M

Inventories %

19.35

20.74

26.84

26.15

20.03

22.62

22.62

22.62

22.62

Payable

400.98M

296.77M

251.07M

287.61M

249.88M

202.7M

172.69M

147.12M

125.34M

106.78M

Payable %

14.52

16.87

15.99

20.71

18.1

17.24

17.24

17.24

17.24

Cap Ex

-33.71M

-36.27M

-27.65M

-23.55M

-23.6M

-19.87M

-16.93M

-14.42M

-12.29M

-10.47M

Cap Ex %

-1.22

-2.06

-1.76

-1.7

-1.71

-1.69

-1.69

-1.69

-1.69

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedin
2017-2024 © Financial Modeling Prep